EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitSystematische ÜbersichtOpen Access

Health-Related Quality of Life and Cost-Effectiveness of First-Line Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor Monotherapy in Advanced EGFR-Mutated Non-small Cell Lung Cancer: A Systematic Review

Subodh Kumar, Shiv K Mudgal, Seshadri Reddy Varikasuvu, Dharmendra Singh, Harminder Singh, Sumit Mahato, Pradosh Kumar Sarangi, Himel Mondal

Cureus · 23.08.2026

DOI: 10.7759/cureus.115032 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cureus, erschienen am 23.08.2026. Verfasst von Subodh Kumar und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, All India Institute of Medical Sciences, Deoghar, IND. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

cost-effectivenesseconomic evaluationegfr tyrosine kinase inhibitorsegfr-mutated nsclcfirst-line therapyhealth-related quality of lifenon-small cell lung cancerpatient-reported outcomesprecision oncologysystematic review

Autor:innen und Institutionen

  • Department of Pharmacology, All India Institute of Medical Sciences, Deoghar, IND.
  • Department of Evidence Synthesis (DOES), All India Institute of Medical Sciences, Deoghar, IND.
  • College of Nursing, Dr. Ram Manohar Lohia Institute of Medical Sciences, Lucknow, IND.
  • Department of Biochemistry, All India Institute of Medical Sciences, Deoghar, IND.
  • Department of Radiation Oncology, All India Institute of Medical Sciences, Deoghar, IND.
  • Department of Radiodiagnosis, All India Institute of Medical Sciences, Deoghar, IND.

Zitieren

APA

Kumar, S., Mudgal, S. K., Varikasuvu, S. R., Singh, D., Singh, H., Mahato, S., Sarangi, P. K., & Mondal, H. (2026). Health-Related Quality of Life and Cost-Effectiveness of First-Line Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor Monotherapy in Advanced EGFR-Mutated Non-small Cell Lung Cancer: A Systematic Review. Cureus. https://doi.org/10.7759/cureus.115032

Vancouver

Kumar S, Mudgal SK, Varikasuvu SR, Singh D, Singh H, Mahato S, et al. Health-Related Quality of Life and Cost-Effectiveness of First-Line Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor Monotherapy in Advanced EGFR-Mutated Non-small Cell Lung Cancer: A Systematic Review. Cureus. 2026. doi:10.7759/cureus.115032

BibTeX
@article{Kumar2026,
  author = {Kumar, Subodh and Mudgal, Shiv K and Varikasuvu, Seshadri Reddy and Singh, Dharmendra and Singh, Harminder and Mahato, Sumit and Sarangi, Pradosh Kumar and Mondal, Himel},
  title = {Health-Related Quality of Life and Cost-Effectiveness of First-Line Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor Monotherapy in Advanced EGFR-Mutated Non-small Cell Lung Cancer: A Systematic Review},
  journal = {Cureus},
  year = {2026},
  doi = {10.7759/cureus.115032}
}
Kostenlos starten →